Sign in
Active, not recruitingNo phase

FreeDom: Innovative Strategy for the Management of COPD Exacerbations

Key facts

Who runs it
Laval University
Where
Canada1 site in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
100 people, planned
Started
24 May 2018
Expected to end
Dec 2030
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Control
  • FreeDom
Record updated
4 November 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • All patients hospitalized for COPD exacerbation for less than 48 hours will be considered
  • known or suspected COPD to entry
  • Age > or = 40 years
  • Ex-smoker history (10 pack / year or more)
  • Acute Exacerbation: dyspnea of recent onset (less than 15 days)
  • The need for oxygen therapy with a moderate rate: <6L / min to maintain SpO2 > 90% (for oxygen dependent patient, the oxygen flow must be higher than flow at home)

Who cannot take part

  • Refusal to consent to participate in the study,
  • Indication for an imminent intubation according to the pulmonologist,
  • Sleep Apnea
  • NIV used at home
  • Lack of FreeO2 system available at the time of randomization
  • Non-autonomous and alone at home
  • Patient alone at home
  • Patients who live more than 50 km from the hospital
  • Patient already included in the study within 3 months

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The main objective of the study is to assess the "FreeDom" innovative strategy (FreeO2 at Domicile) to reduce hospitalization duration in patients with COPD exacerbation. This strategy associates early hospital discharge, automated O2 flow weaning with FreeO2 system, telemedicine and tele-rehabilitation.

Read full original descriptionShow less

The main hypothesis of this study is that the FreeDom strategy will reduce the number of hospitalization day by 50 percent at day 30.

The 2 groups in the trial

  • ControlOther group

    The intervention is an hospitalization with usual care. The hospitalization will take place in the usual setting and the hospital discharge will be decided by pulmonologists according to the usual criteria

  • FreeDomExisting treatment, for comparison

    FreeDom strategy (early discharge, automated weaning at home, telemedicine, telereadaptation): -initial conventional hospitalization before discharge home, O2 flow rate automatically titrated by FreeO2 (based on a SpO2 target). The hospital discharge will be possible if the definite criteria are met. After hospital discharge, patient will have home hospitalisation. Automated oxygen flow titration, patient education will be conducted for using the telemedicine system, for questionnaires and for the tele-rehabilitation program will be initiated for home hospitalization,

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
FreeDom : Innovative Strategy for the Management of COPD Exacerbations Combining Early Hospitalisation Discharge, Automated Oxygen Weaning at Home, Telemedicine and Tele-rehabilitation
Record updated
4 November 2026